Ate de-escalation, to make use of these brokers to treat other bacterial infections or to circumvent spreading and colonization.Table 12 (Summary P092). Correlation concerning the share of ventilated clients produced VAP and use.Slope Imipenem Meropenem Tigecyclin Linezoline Colistin -0.02 0.08 0.ten 0.00 0.32 S. E. 0.04 0.10 0.06 0.01 0.twenty r -0.32 0.43 0.sixty six 0.thirteen 0.67 r2 0.10 0.19 0.43 0.01 0.forty five L. CI -0.17 -0.24 -0.11 -0.03 -0.32 U.CI 0.twelve 0.42 0.31 0.04 0.ninety six p benefit 0.388 0.460 0.223 0.834 0.P093 A comparison of two ventilator involved pneumonia surveillance techniques T. H. Craven1, G. Wojcik1, K. Kefala1, J. McCoubrey2, J. Reilly2, R. Paterson3, D. Inverarity1, I. Laurenson1, T. S.